Cargando…
A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645267/ http://dx.doi.org/10.1186/2051-1426-3-S2-P158 |
| _version_ | 1782400796410773504 |
|---|---|
| author | Lu, Yong-Chen Parker, Linda Lu, Tangying Zheng, Zhili Yao, Xin Robbins, Paul F van der Bruggen, Pierre Klebanoff, Christopher A Hinrichs, Christian S Goff, Stephanie Sherry, Richard Kammula, Udai Yang, James C Rosenberg, Steven A |
| author_facet | Lu, Yong-Chen Parker, Linda Lu, Tangying Zheng, Zhili Yao, Xin Robbins, Paul F van der Bruggen, Pierre Klebanoff, Christopher A Hinrichs, Christian S Goff, Stephanie Sherry, Richard Kammula, Udai Yang, James C Rosenberg, Steven A |
| author_sort | Lu, Yong-Chen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645267 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46452672015-11-20 A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers Lu, Yong-Chen Parker, Linda Lu, Tangying Zheng, Zhili Yao, Xin Robbins, Paul F van der Bruggen, Pierre Klebanoff, Christopher A Hinrichs, Christian S Goff, Stephanie Sherry, Richard Kammula, Udai Yang, James C Rosenberg, Steven A J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645267/ http://dx.doi.org/10.1186/2051-1426-3-S2-P158 Text en Copyright © 2015 Lu et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Lu, Yong-Chen Parker, Linda Lu, Tangying Zheng, Zhili Yao, Xin Robbins, Paul F van der Bruggen, Pierre Klebanoff, Christopher A Hinrichs, Christian S Goff, Stephanie Sherry, Richard Kammula, Udai Yang, James C Rosenberg, Steven A A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers |
| title | A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers |
| title_full | A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers |
| title_fullStr | A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers |
| title_full_unstemmed | A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers |
| title_short | A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers |
| title_sort | phase i study of an hla-dpb1*0401-restricted t cell receptor targeting mage-a3 for patients with metastatic cancers |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645267/ http://dx.doi.org/10.1186/2051-1426-3-S2-P158 |
| work_keys_str_mv | AT luyongchen aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT parkerlinda aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT lutangying aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT zhengzhili aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT yaoxin aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT robbinspaulf aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT vanderbruggenpierre aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT klebanoffchristophera aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT hinrichschristians aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT goffstephanie aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT sherryrichard aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT kammulaudai aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT yangjamesc aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT rosenbergstevena aphaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT luyongchen phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT parkerlinda phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT lutangying phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT zhengzhili phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT yaoxin phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT robbinspaulf phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT vanderbruggenpierre phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT klebanoffchristophera phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT hinrichschristians phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT goffstephanie phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT sherryrichard phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT kammulaudai phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT yangjamesc phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers AT rosenbergstevena phaseistudyofanhladpb10401restrictedtcellreceptortargetingmagea3forpatientswithmetastaticcancers |